Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

How differing methods of ascribing ethnicity and socio-economic status affect risk estimates for hospitalisation with infectious disease.

Hobbs MR, Atatoa Carr P, Fa'alili-Fidow J, Pillai A, Morton SMB, Grant CC.

Epidemiol Infect. 2018 Nov 13:1-9. doi: 10.1017/S0950268818002935. [Epub ahead of print]

2.

Staphylococcus aureus colonisation and its relationship with skin and soft tissue infection in New Zealand children.

Hobbs MR, Grant CC, Thomas MG, Berry S, Morton SMB, Marks E, Ritchie SR.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):2001-2010. doi: 10.1007/s10096-018-3336-1. Epub 2018 Jul 31.

PMID:
30066280
3.

Implementing Electronic Health Record Default Settings to Reduce Opioid Overprescribing: A Pilot Study.

Zivin K, White JO, Chao S, Christensen AL, Horner L, Petersen DM, Hobbs MR, Capreol G, Halbritter KA, Jones CM.

Pain Med. 2019 Jan 1;20(1):103-112. doi: 10.1093/pm/pnx304.

PMID:
29325160
4.

An Adult Zebrafish Diet Contaminated with Chromium Reduces the Viability of Progeny.

Tye MT, Montgomery JE, Hobbs MR, Vanpelt KT, Masino MA.

Zebrafish. 2018 Apr;15(2):179-187. doi: 10.1089/zeb.2017.1514. Epub 2018 Jan 2.

5.

Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years.

Hobbs MR, Grant CC, Ritchie SR, Chelimo C, Morton SMB, Berry S, Thomas MG.

J Antimicrob Chemother. 2017 Jun 1;72(6):1832-1840. doi: 10.1093/jac/dkx060.

PMID:
28333294
6.

Ethnic disparities in infectious disease hospitalisations in the first year of life in New Zealand.

Hobbs MR, Morton SM, Atatoa-Carr P, Ritchie SR, Thomas MG, Saraf R, Chelimo C, Harnden A, Camargo CA, Grant CC.

J Paediatr Child Health. 2017 Mar;53(3):223-231. doi: 10.1111/jpc.13377. Epub 2016 Oct 7.

PMID:
27714893
7.

Controlling Endemic Pathogens-Challenges and Opportunities.

Hobbs MR, Shankaran SS, James WL.

Zebrafish. 2016 Jul;13 Suppl 1:S66-71. doi: 10.1089/zeb.2015.1207. Epub 2016 Mar 16.

8.

Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.

Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV.

N Engl J Med. 2013 Jun 27;368(26):2476-2486. doi: 10.1056/NEJMoa1300253.

9.

Deep sequencing for the detection of virus-like sequences in the brains of patients with multiple sclerosis: detection of GBV-C in human brain.

Kriesel JD, Hobbs MR, Jones BB, Milash B, Nagra RM, Fischer KF.

PLoS One. 2012;7(3):e31886. doi: 10.1371/journal.pone.0031886. Epub 2012 Mar 8.

10.

C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene.

Kriesel JD, Jones BB, Matsunami N, Patel MK, St Pierre CA, Kurt-Jones EA, Finberg RW, Leppert M, Hobbs MR.

J Infect Dis. 2011 Dec 1;204(11):1654-62. doi: 10.1093/infdis/jir633.

11.

A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

Malar J. 2010 Oct 29;9:302. doi: 10.1186/1475-2875-9-302.

12.

Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

J Infect Dis. 2010 Jul 1;202(1):117-24. doi: 10.1086/653125.

13.

Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB.

Hum Genet. 2010 Feb;127(2):163-82. doi: 10.1007/s00439-009-0753-3. Epub 2009 Oct 27.

14.

Identification of a herpes simplex labialis susceptibility region on human chromosome 21.

Hobbs MR, Jones BB, Otterud BE, Leppert M, Kriesel JD.

J Infect Dis. 2008 Feb 1;197(3):340-6. doi: 10.1086/525540.

PMID:
18199027
15.

Coding and non-coding polymorphisms in alcohol dehydrogenase alters protein expression and alcohol-associated erythema.

Pershing LK, Chen Y, Tkachuk AN, Rausch HL, Petelenz-Rubin K, Corlett JL, Hobbs MR.

J Invest Dermatol. 2008 Mar;128(3):616-27. Epub 2007 Nov 29.

16.

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, Tjitra E, Maniboey H, Hobbs MR, Levesque MC, Weinberg JB, Granger DL.

Infect Immun. 2006 Jun;74(6):3355-9.

17.

Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.

Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE, Laidler P, Manek S, Robbins CM, Salti IS, Thompson NW, Jackson CE, Thakker RV.

J Intern Med. 2005 Jan;257(1):18-26.

18.

Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.

Boutlis CS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Anstey NM.

Am J Trop Med Hyg. 2003 Dec;69(6):569-73.

PMID:
14740870
19.

Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production.

Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL.

Lancet. 2003 Feb 22;361(9358):676-8.

PMID:
12606182
20.

Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.

Oates JC, Levesque MC, Hobbs MR, Smith EG, Molano ID, Page GP, Hill BS, Weinberg JB, Cooper GS, Gilkeson GS.

J Rheumatol. 2003 Jan;30(1):60-7.

PMID:
12508391
21.

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Höög A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR.

Nat Genet. 2002 Dec;32(4):676-80. Epub 2002 Nov 18.

PMID:
12434154
22.

A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.

Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB.

Lancet. 2002 Nov 9;360(9344):1468-75. Erratum in: Lancet. 2003 Feb 1;361(9355):438..

PMID:
12433515
23.

A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production.

Morahan G, Boutlis CS, Huang D, Pain A, Saunders JR, Hobbs MR, Granger DL, Weinberg JB, Peshu N, Mwaikambo ED, Marsh K, Roberts DJ, Anstey NM.

Genes Immun. 2002 Nov;3(7):414-8.

24.

Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2.

Hobbs MR, Rosen IB, Jackson CE.

Am J Hum Genet. 2002 May;70(5):1376-7. No abstract available.

25.

An immunologically anomolous parathyroid hormone variant causing hyperparathyroidism.

Odell WD, Hobbs MR, Benowitz B.

Clin Endocrinol (Oxf). 2001 Sep;55(3):417-20. No abstract available.

PMID:
11589687
26.

Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.

Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB.

J Infect Dis. 1999 Dec;180(6):1994-2002. Erratum in: J Infect Dis 2000 Jan;181(1):408.

PMID:
10558957
27.

Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q.

Hobbs MR, Pole AR, Pidwirny GN, Rosen IB, Zarbo RJ, Coon H, Heath H 3rd, Leppert M, Jackson CE.

Am J Hum Genet. 1999 Feb;64(2):518-25.

28.

A physical map encompassing GP2B, EPB3, D17S183, D17S78, D17S1183, and D17S1184.

Miki Y, Swensen JJ, Hobbs MR, DeHoff BS, Rosteck PR, Skolnick MH, Neuhausen SL.

Genomics. 1995 Jan 1;25(1):295-7.

PMID:
7774935
29.

A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1.

Neuhausen SL, Swensen J, Miki Y, Liu Q, Tavtigian S, Shattuck-Eidens D, Kamb A, Hobbs MR, Gingrich J, Shizuya H, et al.

Hum Mol Genet. 1994 Nov;3(11):1919-26.

PMID:
7874107
30.

Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.

Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, Hastings R, Wessling HC, Norcross MA, Fendly BM, Berman PW.

J Virol. 1993 Oct;67(10):6179-91.

31.

Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.

Nakamura GR, Byrn R, Rosenthal K, Porter JP, Hobbs MR, Riddle L, Eastman DJ, Dowbenko D, Gregory T, Fendly BM, et al.

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1875-85.

PMID:
1283308
32.

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1.

Berman PW, Matthews TJ, Riddle L, Champe M, Hobbs MR, Nakamura GR, Mercer J, Eastman DJ, Lucas C, Langlois AJ, et al.

J Virol. 1992 Jul;66(7):4464-9.

33.

Supplemental Content

Loading ...
Support Center